Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,325 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A combination of galantamine and memantine modifies cognitive function in subjects with amnestic MCI.
Peters O, Lorenz D, Fesche A, Schmidtke K, Hüll M, Perneczky R, Rüther E, Möller HJ, Jessen F, Maier W, Kornhuber J, Jahn H, Luckhaus C, Gertz HJ, Schröder J, Pantel J, Teipel S, Wellek S, Frölich L, Heuser I. Peters O, et al. Among authors: moller hj. J Nutr Health Aging. 2012;16(6):544-8. doi: 10.1007/s12603-012-0062-8. J Nutr Health Aging. 2012. PMID: 22659994 Free article. Clinical Trial.
What are depressive symptoms in acutely ill patients with schizophrenia spectrum disorder?
Schennach R, Riedel M, Obermeier M, Seemüller F, Jäger M, Schmauss M, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Maier W, Lemke MR, Rüther E, Klingberg S, Gastpar M, Möller HJ. Schennach R, et al. Among authors: moller hj. Eur Psychiatry. 2015 Jan;30(1):43-50. doi: 10.1016/j.eurpsy.2014.11.001. Epub 2014 Dec 22. Eur Psychiatry. 2015. PMID: 25541347
Insight in schizophrenia-course and predictors during the acute treatment phase of patients suffering from a schizophrenia spectrum disorder.
Schennach R, Meyer S, Seemüller F, Jäger M, Schmauss M, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Maier W, Lemke MR, Rüther E, Klingberg S, Gastpar M, Möller HJ, Riedel M. Schennach R, et al. Among authors: moller hj. Eur Psychiatry. 2012 Nov;27(8):625-33. doi: 10.1016/j.eurpsy.2012.01.001. Epub 2012 Apr 28. Eur Psychiatry. 2012. PMID: 22542652
[Science is invigorated by discussion].
Linden M, Maier W, Möller HJ, Sass H. Linden M, et al. Among authors: moller hj. Nervenarzt. 2009 Nov;80(11):1341-2. doi: 10.1007/s00115-009-2883-1. Nervenarzt. 2009. PMID: 19898888 German. No abstract available.
Time course of antipsychotic treatment response in schizophrenia: results from a naturalistic study in 280 patients.
Jäger M, Riedel M, Obermeier M, Schennach-Wolff R, Seemüller F, Messer T, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Kühn KU, Lemke MR, Rüther E, Klingberg S, Gastpar M, Bottlender R, Möller HJ. Jäger M, et al. Among authors: moller hj. Schizophr Res. 2010 May;118(1-3):183-8. doi: 10.1016/j.schres.2010.02.002. Epub 2010 Feb 23. Schizophr Res. 2010. PMID: 20181461
Evaluating depressive symptoms and their impact on outcome in schizophrenia applying the Calgary Depression Scale.
Schennach-Wolff R, Obermeier M, Seemüller F, Jäger M, Messer T, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Maier W, Lemke MR, Rüther E, Klingberg S, Gastpar M, Möller HJ, Riedel M. Schennach-Wolff R, et al. Among authors: moller hj. Acta Psychiatr Scand. 2011 Mar;123(3):228-38. doi: 10.1111/j.1600-0447.2010.01608.x. Epub 2010 Oct 4. Acta Psychiatr Scand. 2011. PMID: 21029053
Outcome of suicidal patients with schizophrenia: results from a naturalistic study.
Schennach-Wolff R, Jäger M, Seemüller F, Obermeier M, Schmauss M, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Maier W, Lemke MR, Rüther E, Klingberg S, Gastpar M, Möller HJ, Riedel M. Schennach-Wolff R, et al. Among authors: moller hj. Acta Psychiatr Scand. 2010 May;121(5):359-70. doi: 10.1111/j.1600-0447.2009.01484.x. Epub 2009 Oct 30. Acta Psychiatr Scand. 2010. PMID: 19878135
A critical analysis and discussion of the appropriateness of the schizophrenia consensus remission criteria in clinical pharmaceutical trials.
Schennach-Wolff R, Möller HJ, Jäger M, Seemüller F, Obermeier M, Messer T, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Maier W, Lemke MR, Rüther E, Klingberg S, Gastpar M, Riedel M. Schennach-Wolff R, et al. Among authors: moller hj. Pharmacopsychiatry. 2010 Nov;43(7):245-51. doi: 10.1055/s-0030-1262788. Epub 2010 Oct 6. Pharmacopsychiatry. 2010. PMID: 20927697
1,325 results